1-hydroxy-7-oxolavanducyanin and Δ7″,8″-6″-hydroxynaphthomevalin from Streptomyces sp. CPCC 203577


Lavanducyanin is a bioactive phenazine-containing secondary metabolite, and naphthomevalin is an antibacterial polyketide secondary metabolite. Herein, new analogues of lavanducyanin (2) and of naphthomevalin (4), together with lavanducyanin (1) and naphthomevalin (3), were identified from Streptomyces sp. CPCC 203577, an actinomycete soil isolate. The structures of 2 and 4 were elucidated as 1-hydroxy-7-oxolavanducyanin and Δ7″,8″-6″-hydroxynaphthomevalin, respectively, by 1D and 2D NMR. Antibacterial assays revealed that 2 had significant but reduced anti-Gram-positive bacterial activity compared with 1, and 4 was devoid of anti-Gram-positive bacterial activity. This indicated that the phenazinone nucleus in lavanducyanin and the monoterpene side chain in naphthomevalin might be important for their anti-Gram-positive bacterial activity. Compounds 14 were all inactive against Gram-negative bacteria.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2


  1. 1.

    Guttenberger N, Blankenfeldt W, Breinbauer R. Recent developments in the isolation, biological function, biosynthesis, and synthesis of phenazine natural products. Bioorg Med Chem. 2017;25:6149–66.

    CAS  Article  Google Scholar 

  2. 2.

    Laursen JB, Nielsen J. Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem Rev. 2004;104:1663–86.

    CAS  Article  Google Scholar 

  3. 3.

    World Health Organisation. Chemotherapy of leprosy for control programs; report of WHO study groups. WHO Tech Rep Ser. 1982;675:7–33.

    Google Scholar 

  4. 4.

    Nakayama O, Yagi M, Tanaka M, Kiyoto S, Okuhara M, Kohsaka M. WS-9659 A and B, novel testosterone 5 alpha-reductase inhibitors isolated from a Streptomyces. I. Taxonomy, fermentation, isolation, physico-chemical characteristics. J Antibiot. 1989;42:1221–9.

    CAS  Article  Google Scholar 

  5. 5.

    Nakayama O, Shigematsu N, Katayama A, Takase S, Kiyoto S, Hashimoto M, Kohsaka M. WS-9659 A and B, novel testosterone 5 alpha-reductase inhibitors isolated from a Streptomyces. II. Structural elucidation of WS-9659 A and B. J Antibiot. 1989;42:1230–4.

    CAS  Article  Google Scholar 

  6. 6.

    Nakayama O, Arakawa H, Yagi M, Tanaka M, Kiyoto S, Okuhara M, Kohsaka M. WS-9659 A and B, novel testosterone 5 alpha-reductase inhibitors isolated from a Streptomyces. III. Biological characteristics and pharmacological characteristics. J Antibiot. 1989;42:1235–40.

    CAS  Article  Google Scholar 

  7. 7.

    Imai S, Furihata K, Hayakawa Y, Noguchi T, Seto H. Lavanducyanin, a new antitumor substance produced by Streptomyces sp. J Antibiot. 1989;42:1196–8.

    CAS  Article  Google Scholar 

  8. 8.

    Asolkar RN, Singh A, Jensen PR, Aalbersberg W, Carté BK, Feussner KD, Subramani R, DiPasquale A, Rheingold AL, Fenical W. Marinocyanins, cytotoxic bromo-phenazinone meroterpenoids from a marine bacterium from the streptomycete clade MAR4. Tetrahedron. 2017;73:2234–41.

    CAS  Article  Google Scholar 

  9. 9.

    Motohashi K, Sue M, Furihata K, Ito S, Seto H. Terpenoids produced by actinomycetes: napyradiomycins from Streptomyces antimycoticus NT17. J Nat Prod. 2008;71:595–601.

    CAS  Article  Google Scholar 

  10. 10.

    Kondratyuk TP, Park EJ, Yu R, van Breemen RB, Asolkar RN, Murphy BT, Fenical W, Pezzuto JM. Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents. Mar Drugs. 2012;10:451–64.

    CAS  Article  Google Scholar 

  11. 11.

    Jiang W, Si S, Chen X, Wang L, Zhuang X, Zou J, Chen H, Cao L, Feng H, Chen L. Development and application of microbial natural products database. Chin J Antibiot. 2006;31:119–21.

    CAS  Google Scholar 

  12. 12.

    Henkel T, Zeeck A. Secondary metabolites by chemical screening, 15. Structure and absolute configuration of naphthomevalin, a new dihydro-naphthoquinone antibiotic from Streptomyces sp. J Antibiot. 1991;44:665–9.

    CAS  Article  Google Scholar 

  13. 13.

    Ohtani I, Kusumi T, Kashman Y, Kakisawa H. High-Field FT NMR application of Mosher’s method. The absolute configurations of marine terpenoids. J Am Chem Soc. 1991;113:4092–6.

    CAS  Article  Google Scholar 

  14. 14.

    Wu Z, Li S, Li J, Chen Y, Saurav K, Zhang Q, Zhang H, Zhang W, Zhang W, Zhang S, Zhang C. Antibacterial and cytotoxic new napyradiomycins from the marine-derived Streptomyces sp. SCSIO 10428. Mar Drugs. 2013;11:2113–25.

    Article  Google Scholar 

  15. 15.

    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-seventh informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2017. M100-S27.

  16. 16.

    Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne, PA: Clinical and Laboratory Standards Institute; 2015. M07-A10.

Download references


The authors thank Nuclear Magnetic Resonance Center (Institute of Materia Medica, CAMS & PUMC) and Analytical Center of Drugs (Institute of Medicinal Biotechnology, CAMS & PUMC) for the NMR and MS analyses. This work was supported by CAMS Initiative for Innovative Medicine (CAMS-I2M-3-012) and National Infrastructure of Microbial Resources (No. NIMR-2018-3).

Author information



Corresponding authors

Correspondence to Bingya Jiang or Linzhuan Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, S., Hu, X., Li, L. et al. 1-hydroxy-7-oxolavanducyanin and Δ7″,8″-6″-hydroxynaphthomevalin from Streptomyces sp. CPCC 203577. J Antibiot 73, 324–328 (2020). https://doi.org/10.1038/s41429-020-0282-9

Download citation

Further reading


Quick links